BSX
Boston Scientific CorpNYSEHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$85.62B
P/E Ratio
24.10
EPS
$2.39
Beta
0.78
52W High
$109.50
52W Low
$56.05
50-Day MA
$67.33
200-Day MA
$90.23
Dividend Yield
—
Profit Margin
17.30%
Forward P/E
16.95
PEG Ratio
0.69
About Boston Scientific Corp
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Fundamentals
| Revenue (TTM) | $20.61B |
| Gross Profit (TTM) | $14.15B |
| EBITDA | $5.43B |
| Operating Margin | 21.50% |
| Return on Equity | 12.40% |
| Return on Assets | 5.98% |
| Revenue/Share (TTM) | $13.91 |
| Book Value | $16.34 |
| Price-to-Book | 3.50 |
| Price-to-Sales (TTM) | 4.15 |
| EV/Revenue | 4.58 |
| EV/EBITDA | 18.85 |
| Quarterly Earnings Growth (YoY) | 100.00% |
| Quarterly Revenue Growth (YoY) | 11.60% |
| Shares Outstanding | $1.49B |
| Float | $1.48B |
| % Insiders | 0.21% |
| % Institutions | 95.28% |
Historical Volatility
HV 10-Day
66.33%
HV 20-Day
49.41%
HV 30-Day
49.22%
HV 60-Day
55.35%
HV Rank
87.3%
Volatility is currently expanding
Analyst Ratings
Consensus ($85.19 target)
10
Strong Buy24
BuyData last updated: 5/1/2026